These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6748336)

  • 1. [Plasma l-carnitine in patients with chronic hemodialysis. II. Pharmacokinetics of l-carnitine and its replacement therapy in these patients].
    Kudoh Y; Shoji T; Oimatsu H; Kikuchi K; Imura O; Watarai I
    Nihon Jinzo Gakkai Shi; 1984 Feb; 26(2):195-202. PubMed ID: 6748336
    [No Abstract]   [Full Text] [Related]  

  • 2. Carnitine metabolism in patients with chronic renal failure: effect of L-carnitine supplementation.
    Wanner C; Förstner-Wanner S; Rössle C; Fürst P; Schollmeyer P; Hörl WH
    Kidney Int Suppl; 1987 Oct; 22():S132-5. PubMed ID: 3480977
    [No Abstract]   [Full Text] [Related]  

  • 3. [Carnitine metabolism in chronic kidney failure].
    Fiorini F; Patrone E; Castellucci A
    Clin Ter; 1992 Jan; 140(1 Pt 2):31-4. PubMed ID: 1559320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carnitine metabolism in chronic renal failure. Acute effects of carnitine addition to the dialysate during acetate hemodialysis.
    Guarnieri G; Toigo G; Crapesi L; Situlin R; Del Bianco MA; Corsi M; Lo Greco P; Vasile A
    Contrib Nephrol; 1988; 65():1-23. PubMed ID: 3048873
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacokinetics of L-carnitine in patients with end-stage renal disease undergoing long-term hemodialysis.
    Evans AM; Faull R; Fornasini G; Lemanowicz EF; Longo A; Pace S; Nation RL
    Clin Pharmacol Ther; 2000 Sep; 68(3):238-49. PubMed ID: 11014405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocrine-metabolic effects of l-carnitine in patients on regular dialysis treatment.
    Albertazzi A; Capelli P; Di Paolo B; Pola P; Tondi P; Vaccario O
    Proc Eur Dial Transplant Assoc; 1983; 19():302-7. PubMed ID: 6878245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of L-Carnitine supplement on plasma coagulation and anticoagulation factors in hemodialysis patients.
    Hakeshzadeh F; Tabibi H; Ahmadinejad M; Malakoutian T; Hedayati M
    Ren Fail; 2010; 32(9):1109-14. PubMed ID: 20863217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. L-carnitine supplementation and adipokines in patients with end-stage renal disease on regular hemodialysis.
    Csiky B; Nyul Z; Tóth G; Wittmann I; Melegh B; Rauh M; Rascher W; Sulyok E
    Exp Clin Endocrinol Diabetes; 2010 Nov; 118(10):735-40. PubMed ID: 20658442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of L-carnitine supplementation on muscular symptoms in hemodialyzed patients.
    Sakurauchi Y; Matsumoto Y; Shinzato T; Takai I; Nakamura Y; Sato M; Nakai S; Miwa M; Morita H; Miwa T; Amano I; Maeda K
    Am J Kidney Dis; 1998 Aug; 32(2):258-64. PubMed ID: 9708610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L carnitine in hemodialysis patients.
    Calò LA; Vertolli U; Davis PA; Savica V
    Hemodial Int; 2012 Jul; 16(3):428-34. PubMed ID: 22360675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of L-carnitine on respiratory function tests in children undergoing chronic hemodialysis.
    Kavukçu S; Türkmen M; Salman S; Onvural B; Oktay G; Karaman O; Cevik NT
    Turk J Pediatr; 1998; 40(1):79-84. PubMed ID: 9673532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Newer aspects of carnitine metabolism in uremia.
    Savica V; Calvani M; Benatti P; Santoro D; Monardo P; Mallamace A; Savica R; Bellinghieri G
    Semin Nephrol; 2006 Jan; 26(1):52-5. PubMed ID: 16412827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L-carnitine in dialysed patients: the choice of dosage regimen.
    Berard E; Iordache A; Barrillon D; Bayle J
    Int J Clin Pharmacol Res; 1995; 15(3):127-33. PubMed ID: 8847154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of L-carnitine therapy on respiratory function tests in chronic hemodialysis patients.
    Bavbek N; Akay H; Uz B; Uz E; Turgut F; Kanbay M; Senes M; Akcay A; Duranay M
    Ren Fail; 2010 Jan; 32(2):157-61. PubMed ID: 20199175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. L-Propionyl carnitine, homocysteine and S-adenosylhomocysteine in hemodialysis.
    Perna AF; Acanfora F; Satta E; Lombardi C; Capasso R; Ingrosso D; De Santo NG
    J Nephrol; 2007; 20(1):63-5. PubMed ID: 17347975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dialysis-related carnitine disorder.
    Hedayati SS
    Semin Dial; 2006; 19(4):323-8. PubMed ID: 16893411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ketogenic and antiketogenic effects of L-carnitine in hemodialysis patients.
    Wanner C; Wieland H; Wäckerle B; Boeckle H; Schollmeyer P; Hörl WH
    Kidney Int Suppl; 1989 Nov; 27():S264-8. PubMed ID: 2636668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of dialysate composition on the lipid response to L-carnitine supplementation.
    Zilleruelo G; Novak M; Hsia SL; Goldberg R; Abitbol C; Monkus E; Strauss J
    Kidney Int Suppl; 1989 Nov; 27():S259-63. PubMed ID: 2699997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of L-carnitine on leukocyte function and viability in hemodialysis patients: A double-blind randomized trial.
    Thomas S; Fischer FP; Mettang T; Pauli-Magnus C; Weber J; Kuhlmann U
    Am J Kidney Dis; 1999 Oct; 34(4):678-87. PubMed ID: 10516349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of L-carnitine on erythropoiesis and blood platelet aggregation in patients with chronic renal failure treated with hemodialysis].
    Kalinowski M; Popławski A; Mazerska M; Daniluk A
    Pol Merkur Lekarski; 1999 Feb; 6(32):76-8. PubMed ID: 10337176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.